Viewing Study NCT00078312

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 10:46 PM
Ignite Modification Date: 2025-12-26 @ 10:46 PM
Study NCT ID: NCT00078312
Status: COMPLETED
Last Update Posted: 2013-07-19
First Post: 2004-02-23
Is NOT Gene Therapy: False
Has Adverse Events: True
Brief Title: Armodafinil (CEP-10953) for Treatment of Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder
Sponsor: Cephalon
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Narcolepsy View
None Sleep Apnea, Obstructive View
None Sleep Apnea Syndromes View
None Shift-Work Sleep Disorder View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Excessive Sleepiness View
None Narcolepsy View
None Cataplexy View
None Sleep Attacks View
None Obstructive Sleep Apnea View
None Obstructive Sleep Hypopnea View
None nCPAP View
None Chronic Shift Work Sleep Disorder View
None Chronic SWSD View
None Circadian Rhythm Disorder View
None Shift Worker View
None Cepahlon View
None Cephalon, Inc View
None Nuvigil View